Editors Choice

Will Blood Glucose Become The New Blood Pressure?

It is possible that tracking blood sugar levels could become a more commonly used metric in healthcare, similar to how blood pressure is used to track patients’ health?  Recently, news from Apple suggests that watch-based blood glucose measurement is in “the proof of concept stage.”

Blood sugar levels are already routinely monitored in patients with diabetes or those at risk of developing diabetes, but the importance of maintaining stable blood sugar levels for overall health is becoming more widely recognized. Elevated blood sugar levels, even if not high enough to indicate diabetes, may be associated with an increased risk of cardiovascular disease, kidney disease, and other health problems.

As a result, tracking blood sugar levels without diabetes or pre-diabetes may become a tool for managing both disease and wellness. Or perhaps, availability of broader data sets can foster research examine blood glucose levels and trajectory to offer new insights into the pathophysiology of related diseases at earlier points in time.

Digital health has often offered monitoring solutions that reside in the consumers hands (or wrists). And this has certainly been a mixed blessing.  Some tools have provided valuable insights into health.  Yet some have become merely a source of arbitrary information that cannot be translated into clinical value.  Further, this added burden to healthcare providers may further preclude adoption.  But as innovation has taught us, the next big thing can often be close at hand.  The emergence of continuous blood glucose monitoring (CGM) has been transformative for patients.  And the new data sets have given scientists powerful insights into glucose kinetics and insulin administration.   And these insights maybe game-changing with the global concerns of obesity and metabolic syndrome.

Your watch is becoming a value tool in wellness and disease management.  And that value is only beginning to be realized and implemented.

John Nosta

John is the founder of NostaLab, a digital health think tank recognized globally for an inspired vision of digital transformation. His focus is on guiding companies, NGOs, and governments through the dynamics of exponential change and the diffusion of innovation into complex systems. He is also a member of the Google Health Advisory Board and the WHO’s Digital Health Roster of Experts. He is a frequent and popular contributor to Fortune, Forbes, Psychology Today and Bloomberg as well as prestigious peer-reviewed journals including The American Journal of Physiology, Circulation, and The American Journal of Hematology.

Recent Posts

Biotech Without Borders: Reclaiming the Wonder of Science in a Distracted Age

I was in the media bullpen with the team when the future arrived. The launch…

2 days ago

AI-Powered Obesity Care: FlyteHealth Delivers Big Wins for Connecticut’s Public Employees

In an era where access to effective obesity care remains mired in controversy over medication…

2 days ago

BIO – Biotech Without Borders

This year’s gathering in Boston—a city long synonymous with health innovation—welcomed more than 20,000 attendees…

3 days ago

Clinic Notes: I Didn’t Expect to Speak Japanese Today

He came in wearing a loose hospital gown, but he carried himself like a man…

3 days ago

Simple Isometric Exercises to Build Strength and Mental Wellness for All Ages

Isometric exercises are ideal for incorporating into your regular routines, as they involve engaging muscles without…

3 days ago

Blending Renaissance Thinking and Collaborative Power to Address Global Health Challenges

When I first encountered Yasushi Yamamoto—musician, philosopher, investor, and Founder and CEO of Corundum—I was…

1 week ago

This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.

Read More